ID Source | ID |
---|---|
PubMed CID | 3080935 |
MeSH ID | M0092386 |
Synonym |
---|
l-cysteine, n-acetyl-, ester with glycine 2-((dichloroacetyl)amino)-3-hydroxy-3-(4-(methylsulfonyl)phenyl)propyl ester, (r-(r*,r*))- |
einecs 278-282-1 |
n-acetyl-l-cysteine, ester with (r-(r*,r*))-2-(dichloroacetamido)-3-hydroxy-3-(p-mesylphenyl)propyl glycinate |
acetylcysteinate ester of thiamphenicol glycinate |
thiamphenicol glycinate acetylcysteinate |
fluimucil antibiotic (tn) |
75639-30-4 |
D08582 |
[(2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-methylsulfonylphenyl)propyl] 2-amino-3-[[(2r)-1-methylsulfanyl-3-oxopropan-2-yl]amino]-3-oxopropanoate |
DTXSID30997070 |
2,2-dichloro-n-{1-hydroxy-1-[4-(methanesulfonyl)phenyl]-3-[(3-{[1-(methylsulfanyl)-3-oxopropan-2-yl]imino}seryl)oxy]propan-2-yl}ethanimidic acid |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 4 (33.33%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (66.67%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
chloramphenicol | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
acetylcysteine | acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid | antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary | 1979 | 2006 | 27.7 | high | 2 | 2 | 3 | 4 | 0 | 0 | |
erythromycin | cyclic ketone; erythromycin | 1999 | 1999 | 25.0 | low | 0 | 0 | 2 | 0 | 0 | 0 | ||
thiamphenicol | monocarboxylic acid amide; sulfone | antimicrobial agent; immunosuppressive agent | 1979 | 2006 | 27.7 | high | 2 | 2 | 3 | 4 | 0 | 0 | |
amoxicillin | penicillin allergen; penicillin | antibacterial drug | 1999 | 1999 | 25.0 | low | 0 | 0 | 2 | 0 | 0 | 0 | |
thiamphenicol glycinate | alpha-amino acid ester | 1979 | 2002 | 30.0 | high | 1 | 1 | 0 | 2 | 0 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute Disease | 0 | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 | |
Bacterial Pneumonia | 0 | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
Bronchitis | 0 | 2002 | 2002 | 22.0 | low | 1 | 0 | 0 | 1 | 0 | 0 | |
Cough | 0 | 2002 | 2002 | 22.0 | low | 1 | 0 | 0 | 1 | 0 | 0 | |
Group A Strep Infection | 0 | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
Haemophilus Infections | 0 | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
Infections, Respiratory | 0 | 1980 | 2006 | 29.0 | medium | 1 | 1 | 1 | 1 | 0 | 0 | |
Pneumonia, Bacterial | 0 | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
Respiratory Tract Diseases | 0 | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 | |
Respiratory Tract Infections | 0 | 1980 | 2006 | 29.0 | medium | 1 | 1 | 1 | 1 | 0 | 0 | |
Streptococcal Infections | 0 | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Article | Year |
---|---|
Recent clinical evidence of the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate. Journal of chemotherapy (Florence, Italy), , Volume: 14, Issue:3 | 2002 |
Article | Year |
---|---|
Aerosol antibiotic therapy in children with chronic upper airway infections: a potential alternative to surgery. International journal of immunopathology and pharmacology, , Volume: 22, Issue:2 | |
Recent clinical evidence of the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate. Journal of chemotherapy (Florence, Italy), , Volume: 14, Issue:3 | 2002 |